Cancer BiologybioRxivPreprint
Synergy of HLA class I and II shapes the timing of antitumor immune response
B. T. Papp, A. T. Fulop, G. M. Balogh…·M. Manczinger
The paper examines how combinations of HLA class I and II variants affect antitumor immune response timing and patient survival in melanoma.
DOI 10.1101/2022.11.16.516740